Expression pattern of the urokinase-plasminogen activator system in rat DS-sarcoma: Role of oxygenation status and tumour size

British Journal of Cancer

Volumn 86, Issue 8, 2002, Pages 1355-1361

  Weinmann, M ^a   Thews, O ^a   Schroeder, T ^a   Vaupel, P ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

DS sarcoma; Hypoxia; Malignant progression; Plasminogen activator inhibitor type I; Urokinase plasminogen activator; Urokinase plasminogen activator receptor

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE; UROKINASE RECEPTOR;

AMBIENT AIR; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER GRAFT; CELL HYPOXIA; CONTROLLED STUDY; FLOW CYTOMETRY; HYPEROXIA; HYPOXIA; MALIGNANT TRANSFORMATION; NONHUMAN; OXYGENATION; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; REPRODUCIBILITY; RNA ANALYSIS; SARCOMA; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; ANOXIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; ORGAN SPECIFICITY; OXYGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; RATS; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SARCOMA; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0037156946     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600237     Document Type: Article

References (36)

1. The urokinase-type plasminogen activator system in cancer metastasis: A review
2. The plasminogen activation system in tumor growth, invasion and metastasis
3. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
4. Tumor oxygenation predicts for the likelyhood of distant metastases in human soft tissue sarcoma
5. Isolation and characterization of the rat plasminogen activator inhibitor-1 gene
6. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration
7. Hypoxia modulated gene expression: Angiogenesis, metastasis and therapeutic exploitation
8. Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway
9. Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression
10. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix
11. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix
12. Hypoxic cervical cancers with low apoptotic index are highly aggressive
13. Tumor hypoxia: Definitions and current clinical, biologic and molecular aspects
14. Hypoxyradiotherapy: Lack of experimental evidence for a preferential radioprotective effect on normal versus tumor tissue as shown by direct oxygenation measurements in experimental sarcoma
15. Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes
16. Candidate genes for the hypoxic tumor phenotype
17. Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis
18. Regulation of the urokinase-type plasminogen activator system by the von Hippel-Lindau tumor suppressor gene
19. Both increased stability and transcription contribute to the induction of the urokinase plasminogen activator receptor (uPAR) message by hypoxia
20. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy
21. Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p53 mutations
22. Design and testing of beta-actin primers for RT-PCR that do not co-amplify processed pseudogenes
23. Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis
24. Microenvironment-induced cancer metastasis
25. HIF-1: Mediator of physiological and pathophysiological responses to hypoxia
26. In situ stromal expression of the urokinase/plasmin system correlates with epithelial dysplasia in colorectal adenomas
27. Melanoma cell migration on vitronectin: Regulation by components of the plasminogen activation system
28. The plasminogen-plasminogen activator (PA) system in neuroblastoma: Role of PA inhibitor-1 in metastasis
29. Tumor hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix
30. 2 concentrations
31. Amiloride selectively inhibits the urokinase-type plasminogen activator
32. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review
33. Blood flow and tissue oxygenation of human tumors: An update
34. Current status of knowledge and critical issues in tumor oxygenation. Results from 25 years research in tumor pathophysiology
35. United Kingdom Committee on Cancer Research (UKCCCR) Guidelines for the welfare of animals in experimental neoplasia
36. Expression and localization for plasminogen activator inhibitor type 1 in human astrocytoma in vivo